Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer
Swaathi Jayaraman(Johns Hopkins University), Matthew P. Goetz(Mayo Clinic)
Cited by 10
Related Papers
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
|npj Breast Cancer|2019|673
(untitled)
|Edinburgh Research Explorer|0|353
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2021|255
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer
|Breast Cancer Research and Treatment|2017|95